2020 annual financial data

XTL Biopharmaceuticals 2020 Net margin

XTL Biopharmaceuticals 2020 net margin with verified reported values.

Direct answer

Net margin was -2,792.86%.

Operating income was -948,000 USD and net income was -782,000 USD.
Operating cash flow was -850,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
28,000 USD
Operating income
-948,000 USD
Net income
-782,000 USD
Operating cash flow
-850,000 USD